Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NB2004 Trial Protocol for Risk Adapted Treatment of Children With Neuroblastoma

NCT00410631 is registered in ClinicalTrials.gov with German Society for Pediatric Oncology and Hematology GPOH gGmbH as lead sponsor.

NCT NCT00410631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00410631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NB2004 Trial Protocol for Risk Adapted Treatment of Children With Neuroblastoma
Lead sponsor
German Society for Pediatric Oncology and Hematology GPOH gGmbH
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2004
Completion date
Not reported
Enrollment
642 (estimated)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma